Total Payments
$10,984
2024 Payments
$874.19
Companies
49
Transactions
532
Medicare Patients
3,498
Medicare Billing
$316,204
Payment Breakdown by Category
Food & Beverage$10,944 (99.6%)
Education$39.78 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,944 | 526 | 99.6% |
| Education | $39.78 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,339 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,084 | 32 | $0 (2024) |
| PFIZER INC. | $973.23 | 58 | $0 (2024) |
| Allergan, Inc. | $945.13 | 66 | $0 (2020) |
| Lilly USA, LLC | $922.99 | 60 | $0 (2024) |
| Amarin Pharma Inc. | $663.20 | 32 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $607.31 | 26 | $0 (2021) |
| ABBVIE INC. | $508.02 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $494.66 | 17 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $418.65 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $874.19 | 42 | AstraZeneca Pharmaceuticals LP ($133.43) |
| 2023 | $1,025 | 44 | Paratek Pharmaceuticals, Inc. ($163.63) |
| 2022 | $1,070 | 49 | Lilly USA, LLC ($246.02) |
| 2021 | $1,448 | 64 | Novo Nordisk Inc ($290.53) |
| 2020 | $1,112 | 64 | Allergan, Inc. ($295.11) |
| 2019 | $1,227 | 72 | Novo Nordisk Inc ($295.47) |
| 2018 | $1,630 | 81 | Allergan Inc. ($297.54) |
| 2017 | $2,599 | 116 | SANOFI-AVENTIS U.S. LLC ($378.71) |
All Payment Transactions
532 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: GI | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.81 | General |
| 10/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: GI | ||||||
| 10/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Oncology | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Silk Road Medical, Inc. | ENROUTE Transcarotid Neuroprotection System (Device), ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.59 | General |
| Category: GI | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.21 | General |
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Endocrinology | ||||||
| 06/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Oncology | ||||||
| 06/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Biological | ||||||
| 06/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: VACCINES | ||||||
| 05/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Diabetes Care | ||||||
| 05/23/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.06 | General |
| 05/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Gastroenterology | ||||||
| 05/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 591 | 827 | $137,541 | $59,196 |
| 2022 | 10 | 720 | 960 | $144,447 | $66,221 |
| 2021 | 17 | 1,024 | 1,516 | $209,045 | $99,208 |
| 2020 | 19 | 1,163 | 1,598 | $219,400 | $91,579 |
Total Patients
3,498
Total Services
4,901
Medicare Billing
$316,204
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 373 | $76,838 | $28,769 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 154 | 154 | $28,490 | $18,586 | 65.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 24 | $12,888 | $4,928 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 66 | $9,240 | $3,758 | 40.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 22 | 47 | $4,559 | $1,306 | 28.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 25 | 25 | $3,125 | $886.88 | 28.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $504.00 | $347.88 | 69.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 35 | $1,260 | $324.73 | 25.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 65 | 91 | $637.00 | $289.25 | 45.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 191 | 352 | $72,512 | $28,888 | 39.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 175 | 175 | $32,375 | $21,682 | 67.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 20 | 21 | $11,277 | $4,395 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 86 | $12,040 | $4,359 | 36.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 34 | $3,604 | $2,314 | 64.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 30 | 45 | $4,365 | $1,349 | 30.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 28 | 29 | $3,625 | $1,156 | 31.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 42 | $1,764 | $1,151 | 65.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 54 | 57 | $2,052 | $546.02 | 26.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 72 | 119 | $833.00 | $381.59 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 203 | 203 | $37,555 | $25,797 | 68.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 179 | 268 | $55,208 | $21,832 | 39.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 249 | $29,880 | $14,639 | 49.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 176 | 234 | $32,760 | $11,592 | 35.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 50 | $8,600 | $4,098 | 47.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 26 | $8,736 | $4,089 | 46.8% |
About Dr. James Mwatibo, MD
Dr. James Mwatibo, MD is a Family Medicine healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710975487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Mwatibo, MD has received a total of $10,984 in payments from pharmaceutical and medical device companies, with $874.19 received in 2024. These payments were reported across 532 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($10,944).
As a Medicare-enrolled provider, Mwatibo has provided services to 3,498 Medicare beneficiaries, totaling 4,901 services with total Medicare billing of $316,204. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lafayette, LA
- Active Since 10/07/2005
- Last Updated 06/30/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1710975487
Products in Payments
- FARXIGA (Drug) $833.98
- VRAYLAR (Drug) $794.72
- Vascepa (Drug) $663.20
- Ozempic (Drug) $586.58
- ENTRESTO (Drug) $494.66
- JARDIANCE (Drug) $450.49
- TRULICITY (Drug) $395.52
- TRULANCE (Drug) $338.15
- Kerendia (Drug) $334.91
- CHANTIX (Drug) $241.05
- LYRICA (Drug) $219.11
- LINZESS (Drug) $217.23
- MOUNJARO (Drug) $212.78
- SOLIQUA (Drug) $201.86
- NUZYRA (Drug) $195.67
- BYSTOLIC (Drug) $172.07
- Xultophy 100/3.6 (Drug) $149.00
- JANUVIA (Drug) $145.95
- TOUJEO (Drug) $144.56
- Amitiza (Drug) $141.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lafayette
Dr. Stephen Badylak, Dvm, Md, Phd, DVM, MD, PHD
Family Medicine — Payments: $1.8M
Family Medicine $1.8M
William Bray, M.d, M.D
Family Medicine — Payments: $167,020
Family Medicine $167,020
Michael Iannotti, M.d, M.D
Family Medicine — Payments: $43,574
Family Medicine $43,574
Dr. Matthew Abraham, M.d, M.D
Family Medicine — Payments: $23,305
Family Medicine $23,305
Dr. Darrin Menard, Md, MD
Family Medicine — Payments: $15,683
Family Medicine $15,683
Dr. Geoffrey Mire, Md, MD
Family Medicine — Payments: $15,244
Family Medicine $15,244